This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kurt David Shanebeck: Innovator in Antibody Derivatives
Introduction
Kurt David Shanebeck is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody derivatives. His work focuses on innovative therapeutic solutions that address critical health challenges.
Latest Patents
Kurt David Shanebeck holds a patent for his invention titled "Antibody derivatives." This invention relates to a bivalent, bispecific construct that comprises an anti-IL-6 antibody, or derivative thereof, and an anti-IL-23 antibody, or derivative thereof. The patent also discusses the therapeutic uses of these antibodies, highlighting their potential in treating various conditions.
Career Highlights
Shanebeck is associated with MedImmune Limited, a prominent biotechnology company known for its research and development in innovative therapies. His work at MedImmune has allowed him to contribute to groundbreaking advancements in antibody technology.
Collaborations
Throughout his career, Kurt has collaborated with esteemed colleagues, including Kenneth H Grabstein and William Brady. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field.
Conclusion
Kurt David Shanebeck's contributions to antibody derivatives exemplify the impact of innovation in biotechnology. His work continues to pave the way for new therapeutic approaches that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile